Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Genomic testing and molecular diagnosis among infants with congenital heart disease in the neonatal intensive care unit

Abstract

Objective

To evaluate patterns of genetic testing among infants with CHD at a tertiary care center.

Study design

We conducted a retrospective observational cohort study of infants in the NICU with suspicion of a genetic disorder. 1075 of 7112 infants admitted to BCH had genetic evaluation including 329 with CHD and 746 without CHD. 284 of 525 infants with CHD admitted to CMHH had genetic evaluation. Patterns of testing and diagnoses were compared.

Results

The rate of diagnosis after testing was similar for infants with or without CHD (38% [121/318] vs. 36% [246/676], p = 0.14). In a multiple logistic regression, atrioventricular septal defects were most high associated with genetic diagnosis (odds ratio 29.99, 95% confidence interval 2.69–334.12, p < 0.001).

Conclusions

Infants with suspicion of a genetic disorder with CHD had similar rates of molecular diagnosis as those without CHD. These results support a role for genetic testing among NICU infants with CHD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Data availability

The datasets generated during and/or analysed during the current study are not publicly available due confidentiality but are available from the corresponding author on reasonable request.

References

  1. Wu W, He J, Shao X. Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990–2017. Medicine. 2020;99:e20593.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Giang KW, Mandalenakis Z, Fedchenko M, Eriksson P, Rosengren A, Norman M, et al. Congenital heart disease: changes in recorded birth prevalence and cardiac interventions over the past half-century in Sweden. Eur J Prev Cardiol. 2023;30:169–76.

    Article  PubMed  Google Scholar 

  3. Egbe A, Lee S, Ho D, Uppu S, Srivastava S. Prevalence of congenital anomalies in newborns with congenital heart disease diagnosis. Ann Pediatr Cardiol. 2014;7:86.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Zimmerman MS. Global, regional, and national burden of congenital heart disease, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Child Adolesc Health. 2020;4:185–200.

    Article  Google Scholar 

  5. Pierpont ME, Brueckner M, Chung WK, Garg V, Lacro RV, McGuire AL, et al. Genetic basis for congenital heart disease: revisited: a scientific statement from the American Heart Association. Circulation. 2018;138:e653–e711.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Morton SU, Quiat D, Seidman JG, Seidman CE. Genomic frontiers in congenital heart disease. Nat Rev Cardiol. 2022;19:26–42.

    Article  PubMed  Google Scholar 

  7. Peyvandi S, Lupo PJ, Garbarini J, Woyciechowski S, Edman S, Emanuel BS, et al. 22q11.2 deletions in patients with conotruncal defects: Data from 1,610 consecutive cases. Pediatr Cardiol. 2013;34:1687–94.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Vorstman JAS, Jalali GR, Rappaport AM, Scott C, Emanuel BS, et al. MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q. Hum Mutat. 2006;27:814–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Chaix MA. Genetic testing in congenital heart disease: a clinical approach. World J Cardiol. 2016;8:180.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Smith HS, Swint JM, Lalani SR, Otto MCO, Yamal J, Russell HV, et al. Exome sequencing compared with standard genetic tests for critically ill infants with suspected genetic conditions. Genet Med. 2020;22:1303–10.

    Article  CAS  PubMed  Google Scholar 

  11. Yang L, Wei Z, Chen X, Hu L, Peng X, Wang J, et al. Use of medical exome sequencing for identification of underlying genetic defects in <scp>NICU</scp>: experience in a cohort of 2303 neonates in China. Clin Genet. 2022;101:101–9.

    Article  CAS  PubMed  Google Scholar 

  12. Meng L, Pammi M, Saronwala A, Magoulas P, Ghazi AR, Vetrini F, et al. Use of exome sequencing for infants in intensive care units. JAMA Pediatr. 2017;171:e173438.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Wang H, Xiao F, Dong X, Yulan L, Cheng G, Wang L, et al. Diagnostic and clinical utility of next‐generation sequencing in children born with multiple congenital anomalies in the China neonatal genomes project. Hum Mutat. 2021;42:434–44.

    Article  PubMed  Google Scholar 

  14. Wu B, Kang W, Wang Y, Zhuang D, Chen L, Pan X, et al. Application of full-spectrum rapid clinical genome sequencing improves diagnostic rate and clinical outcomes in critically Ill infants in the China neonatal genomes project. Crit Care Med. 2021;49:1674–83.

    Article  CAS  PubMed  Google Scholar 

  15. Lunke S, Eggers S, Wilson M, Patel C, Barnett C, Pinner J, et al. Feasibility of ultra-rapid exome sequencing in critically Ill infants and children with suspected monogenic conditions in the Australian Public Health Care system. JAMA. 2020;323:2503.

    Article  CAS  PubMed  Google Scholar 

  16. Dimmock D, Caylor S, Waldman B, Benson W, Ashburner C, Carmichael J, et al. Project Baby Bear: rapid precision care incorporating rWGS in 5 California children’s hospitals demonstrates improved clinical outcomes and reduced costs of care. Am J Hum Genet. 2021;108:1231–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Bowling KM, Thompson ML, Finnila CR, Hiatt SM, Latner DR, Amaral MD, et al. Genome sequencing as a first-line diagnostic test for hospitalized infants. Genet Med. 2022;24:851–61.

    Article  CAS  PubMed  Google Scholar 

  18. D’Gama AM, Del Rosario MC, Bresnahan MA, Yu TW, Wojcik MH, Agrawal PB. Integrating rapid exome sequencing into NICU clinical care after a pilot research study. NPJ Genom Med. 2022;7:51.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Findley TO, Crain AK, Mahajan S, Deniwar A, Davis J, Zavala AS, et al. Congenital heart defects and copy number variants associated with neurodevelopmental impairment. Am J Med Genet A. 2022;188:13–23.

    Article  CAS  PubMed  Google Scholar 

  20. Elliott AM, Souich C, Lehman A, Guella I, Evans DM, Candido T, et al. RAPIDOMICS: rapid genome-wide sequencing in a neonatal intensive care unit—successes and challenges. Eur J Pediatr. 2019;178:1207–18.

    Article  CAS  PubMed  Google Scholar 

  21. Williamson SL, Rasanayagam CN, Glover KJ, Baptista J, Naik S, Satodia P, et al. Rapid exome sequencing: revolutionises the management of acutely unwell neonates. Eur J Pediatr. 2021;180:3587–91.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Shikany AR, Landis BJ, Parrott A, Miller EM, Coyan A, Walters L. et al. A Comprehensive clinical genetics approach to critical congenital heart disease in infancy. J Pediatr. 2020;227:231–238.e14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Durbin MD, Helvaty LR, Li M, Ware SM. A multicenter cross-sectional study in infants with congenital heart defects demonstrates high diagnostic yield of genetic testing but variable evaluation practices. Genet Med Open. 2023;1:100814.

    Article  Google Scholar 

  24. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86:749–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Gill K, Sasaki J, Jayakar P, Sosa L, Welch E. Chromosomal microarray detects genetic risks of neurodevelopmental disorders in newborns with congenital heart disease. Cardiol Young. 2021;31:1275–82.

    Article  PubMed  Google Scholar 

  26. Wu X, Li R, Fu F, Pan M, Han J, Yang X, et al. Chromosome microarray analysis in the investigation of children with congenital heart disease. BMC Pediatr. 2017;17:117.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Durbin MD, Fairman K, Helvaty LR, Huang M, Li M, Abreu D. et al. Genetic testing guidelines impact care in newborns with congenital heart defects. J Pediatr. 2023;260:113495.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Mone F, Eberhardt RY, Morris RK, Hurles ME, McMullan DJ, Maher ER, et al. COngenital heart disease and the diagnostic yield with exome sequencing (CODE) study: prospective cohort study and systematic review. Ultrasound Obstet Gynecol. 2021;57:43–51.

    Article  CAS  PubMed  Google Scholar 

  29. Paige SL, Saha P, Priest JR. Beyond gene panels: whole exome sequencing for diagnosis of congenital heart disease. Circ Genom Precis Med. 2018;11:e002097.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to thank the infants, families, and providers in the BCH and UT NICUs.

Funding

SUM was supported by an American Heart Association Career Development Award and NIH/NHLBI R03HL150412 and K08HL157653. MW was supported by NIH/NICHD K23HD102589.

Author information

Authors and Affiliations

Authors

Contributions

TOF, PBA, MW and SUM conceptualized this work. EED, TOF, RH, ZSHK, RS, DS, AMD, HAF, MW and SUM participated in the acquisition and analysis of data. EED, TOF, RH, AMD, HAF, PBA, MW and SUM interpreted the data and results. EED, TOF, RH, ZSHD, AMD, PBA, MW and SUM drafted the manuscript. All authors critically reviewed the work for important intellectual content and approved the final version. Each author is accountable for their contribution to the manuscript, including related to the accuracy and integrity of the work.

Corresponding author

Correspondence to Sarah U. Morton.

Ethics declarations

Competing interests

MW has received compensation for consultation to GeneDx, Illumina, and Sanofi. The other authors declare no competing financial interests in relation to the work described.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

D’Souza, E.E., Findley, T.O., Hu, R. et al. Genomic testing and molecular diagnosis among infants with congenital heart disease in the neonatal intensive care unit. J Perinatol (2024). https://doi.org/10.1038/s41372-024-01935-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41372-024-01935-1

Search

Quick links